AUD 0.06
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | 565.91 Thousand | 286.07 Thousand | 127.63 Thousand | 111.95 Thousand | 158.01 Thousand | 91.81 Thousand |
Gross Profit | -565.91 Thousand | -286.07 Thousand | -127.63 Thousand | -111.95 Thousand | -158.01 Thousand | -91.81 Thousand |
Operating Expenses | 8.75 Million | 8.02 Million | 2.15 Million | 3.31 Million | 3.16 Million | 6.09 Million |
Selling, General and Administrative Expenses | 8.75 Million | 8.02 Million | 2.15 Million | 3.31 Million | 3.16 Million | 6.09 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | -4.16 Million | -1.06 Million | -939.27 Thousand | 49.28 Thousand | -307.86 Thousand |
Cost and Expenses | 9.32 Million | 8.3 Million | 2.28 Million | 3.43 Million | 3.32 Million | 6.18 Million |
Operating Income | -9.32 Million | -8.3 Million | -2.28 Million | -3.43 Million | -3.32 Million | -6.18 Million |
Interest Expense | 121.01 Thousand | 259.19 Thousand | 204.71 Thousand | 276.41 Thousand | 142.02 Thousand | 10.13 Thousand |
Income Tax Expense | - | -4.00 | 1.00 | 5.00 | 1.00 | -3.00 |
Earnings before Tax | -9.83 Million | -12.43 Million | -3.54 Million | -4.52 Million | -3.59 Million | -6.17 Million |
Net Income | -9.83 Million | -12.43 Million | -3.54 Million | -4.52 Million | -3.59 Million | -6.17 Million |
Earnings Per Share Basic | -0.01 | -0.01 | -0.00 | -0.01 | -0.01 | -0.01 |
Earnings Per Share Diluted | -0.01 | -0.01 | -0.00 | -0.01 | -0.01 | -0.01 |
Weighted Average Shares Outstanding | 1.27 Billion | 1.13 Billion | 991.26 Million | 835.22 Million | 597.76 Million | 492.77 Million |
Weighted Average Shares Outstanding (Diluted) | 1.28 Billion | 1.13 Billion | 991.26 Million | 835.22 Million | 597.76 Million | 492.77 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -9.06 Million | -11.88 Million | -3.21 Million | -4.13 Million | -3.29 Million | -6.07 Million |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | 343.99 | 221.93 | 173.79 Thousand | 286.07 Thousand | 112.28 Thousand | 69.82 Thousand |
Gross Profit | -343.99 | -221.93 | -173.79 Thousand | -286.07 Thousand | -112.28 Thousand | -69.82 Thousand |
Operating Expenses | 4734.82 | 4383.50 | 4.61 Million | 8.02 Million | 5.88 Million | 3.54 Million |
Selling, General and Administrative Expenses | 4734.82 | 4020.65 | 4.61 Million | - | 5.88 Million | 3.54 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | -4.16 Million | - | - |
Cost and Expenses | 5078.80 | 4605.43 | 4.78 Million | 8.3 Million | 5.99 Million | 3.61 Million |
Operating Income | -5078.80 | -4557.57 | -4.78 Million | -8.3 Million | -5.99 Million | -3.61 Million |
Interest Expense | 61.2 Thousand | 59.8 Thousand | 159.42 Thousand | 259.19 Thousand | 99.76 Thousand | 71.69 Thousand |
Income Tax Expense | -37.91 Thousand | -3.00 | -3.00 | -4.00 | -1.00 | - |
Earnings before Tax | -5515.18 | -4321.71 | -2.86 Million | -12.43 Million | -9.56 Million | -2.31 Million |
Net Income | -5515.18 | -4321.71 | -2.86 Million | -12.43 Million | -9.56 Million | -2.31 Million |
Earnings Per Share Basic | - | -0.00 | -0.00 | - | -0.01 | -0.00 |
Earnings Per Share Diluted | - | -0.00 | -0.00 | - | -0.01 | -0.00 |
Weighted Average Shares Outstanding | 1.28 Billion | 1.27 Billion | 1.27 Billion | 1.13 Billion | 1.17 Billion | 1.02 Billion |
Weighted Average Shares Outstanding (Diluted) | 1.29 Billion | 1.27 Billion | 1.27 Billion | 1.13 Billion | 1.17 Billion | 1.02 Billion |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -5596.31 | -4242.58 | -4.61 Million | - | -5.88 Million | -3.54 Million |
Earnings Before Tax Margin | - | - | - | - | - | - |
S9I
7294
3449
EEG
KNEBV
XEBEQ